Oncologists Accepting Molina Healthcare in Boston, MAPage 3
135 verified oncologists in Boston, Massachusetts accept Molina Healthcare. Profiles cover focus areas including GI Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital.
Peter Enzinger, MD
Director, Center for Esophageal and Gastric Cancer; Associate Professor of Medicine, Harvard Medical School; Institute Physician
Oncology
Lori Wirth, MD
Elizabeth and Michael Ruane Endowed Chair of Medical Oncology; Medical Director, Center for Head and Neck Cancers; Associate Professor of Medicine, Harvard Medical School
Oncology
Michael Constantine, M.D.
Director, Medical Oncology, Dana-Farber Brigham Cancer Center at Milford Regional Medical Center
Oncology
Faina Nakhlis, MD
Assistant Professor of Surgery, Harvard Medical School
Oncology
Narjust Florez, M.D.
Director of the Cancer Care Access Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine res; Assistant Professor of Medicine, Harvard Medical School
Oncology
Thomas Abrams, M.D.
Assistant Professor of Medicine, Harvard Medical School; Institute Physician
Oncology
Rameen Beroukhim, MD
Associate Professor of Medicine, Harvard Medical School
Oncology
Marlise Luskin, M.D.
Assistant Professor of Medicine, Harvard Medical School; Senior Physician, Dana-Farber Cancer Institute; Educational Director, Adult Leukemia Program, Dana-Farber Cancer Institute; Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program
Oncology
Colleen Feltmate, MD
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Her research interests include ovarian cancer, cervical dysplasia
Oncology
Robert Lindsley, MD, PHD
Associate Professor of Medicine, Harvard Medical School; Director, Edward P. Evans Center for Myelodysplastic Syndrome; Director of Clinical Genomics in Hematologic Malignancies
Oncology
Vaishali Sanchorawala, M.D.
Skinner Professor of Amyloidosis Research, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine; Director, Amyloidosis Center; Director, Stem Cell Transplantation Program
Oncology
David Kwiatkowski, MD
Professor of Medicine at Harvard Medical School, and Senior Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. He earned a BSc from Caltec; Senior Physician
Oncology
Jeffrey Clark, MD
Associate Professor, Medicine, Harvard Medical School
Oncology
Lecia Sequist, MD
Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center
Oncology
Alicia Morgans, MD
Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program
Oncology
Frank Hodi, MD
Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center
Oncology
Craig Bunnell, MD
Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hos; Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on
Oncology
Justine Cohen, DO
Senior Physician; Assistant Professor of Medicine, Harvard Medical School
Oncology
Haeseong Park, MD
Medical Oncology
Oncology
Lakshmi Nayak, M.D.
Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma
Oncology